Followers | 28 |
Posts | 3448 |
Boards Moderated | 0 |
Alias Born | 06/30/2012 |
Wednesday, May 28, 2014 7:56:48 PM
I know I bash, but that is because like you my investment is about worthless here. I would like to share something with you and the mods can feel free to sticky if they like. It is my own due diligence. I received this email from Dr. Sharp at NMU today, so take it for what its worth, and I wish lots of hope for all of us here, my name removed from heading.
Hi ,
To answer your question. I am an independent investigator working with MIT. I do have a system in my lab, and we are in the initial stages of working on a Staphylococcus Identifier as the press release stated. However this is NOT a phase I clinical trial. Hopefully once we develop the identifier and test it extensively with known samples, then we can move on to more advanced studies with clinical specimens. We are not at that point yet.
-Josh
Josh Sharp, Ph.D.
Assistant Professor of Biology
Northern Michigan University
New Science Facility
1401 Presque Isle Ave.
Marquette, Michigan 49855
Phone: 906-227-2380
Email: jsharp@nmu.edu
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM